Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemoradiation vs Radiation in Salivary Gland Tumors
NCT01488838Phase 2Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Nov 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in Malignant salivary gland tumor (SGC) (2 arms), sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: Preliminary efficacy data at 2 years. Started Nov 2011; status: completed.
02
Drugs
cisplatin
03
Conditions
Malignant salivary gland tumor (SGC)
Beyond the preview
Go deeper on NCT01488838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01488838.